Spain-based INBRAIN Neuroelectronics has completed patient recruitment for its first-in-human study evaluating a ...
The trial assessed the graphene-based cortical interface during neurosurgical procedures for brain tumour resection.
InBrain Neuroelectronics announced today that it completed patient recruitment in a first-in-human brain-computer interface ...
INBRAIN Neuroelectronics Completes Enrolment of World’s First-in-Human Study of Graphene Neural Interfaces for Brain Decoding ...
Immunofoco today announced the presentation of new preclinical data for its in vivo BCMA-targeting CAR-T candidate, IMV102, at the AACR Annual Meeting 2026. The data demonstrate that IMV102 achieved ...
The National Comprehensive Cancer Network® (NCCN®)--a nonprofit alliance of leading cancer centers--is celebrating a record-breaking year for expanding the reach of essential cancer care resources by ...
The WPDT systems mainly consists of power amplifiers, coils, modulation/demodulation blocks, rectifier and voltage regulator. Modulation schemes (ASK, PSK, FSK) show data encoding methods. The review ...
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced the appointment of Scott Huennekens as Chairman of its ...
INBRAIN Neuroelectronics is gearing up for intelligent brain-computer interface therapeutics by partnering with Microsoft. The company plans to merge its graphene-based neural technology with ...